- Home
- DOCU vs MEDP Comparison
DOCU vs MEDP Comparison
Compare DOCU & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DOCU
- MEDP
- Stock Information
- Founded
- DOCU 2003
- MEDP 1992
- Country
- DOCU United States
- MEDP United States
- Employees
- DOCU N/A
- MEDP N/A
- Industry
- DOCU EDP Services
- MEDP Biotechnology: Commercial Physical & Biological Resarch
- Sector
- DOCU Technology
- MEDP Health Care
- Exchange
- DOCU Nasdaq
- MEDP Nasdaq
- Market Cap
- DOCU 14.6B
- MEDP 13.4B
- IPO Year
- DOCU 2018
- MEDP 2016
- Fundamental
- Price
- DOCU $67.87
- MEDP $593.52
- Analyst Decision
- DOCU Hold
- MEDP Hold
- Analyst Count
- DOCU 17
- MEDP 12
- Target Price
- DOCU $95.62
- MEDP $465.18
- AVG Volume (30 Days)
- DOCU 2.1M
- MEDP 330.7K
- Earning Date
- DOCU 12-04-2025
- MEDP 10-22-2025
- Dividend Yield
- DOCU N/A
- MEDP N/A
- EPS Growth
- DOCU N/A
- MEDP 25.36
- EPS
- DOCU 1.33
- MEDP 14.32
- Revenue
- DOCU $3,095,362,000.00
- MEDP $2,358,373,000.00
- Revenue This Year
- DOCU $9.55
- MEDP $21.48
- Revenue Next Year
- DOCU $6.78
- MEDP $11.90
- P/E Ratio
- DOCU $50.81
- MEDP $41.23
- Revenue Growth
- DOCU 8.29
- MEDP 13.88
- 52 Week Low
- DOCU $65.84
- MEDP $250.05
- 52 Week High
- DOCU $107.86
- MEDP $625.00
- Technical
- Relative Strength Index (RSI)
- DOCU 40.54
- MEDP 61.33
- Support Level
- DOCU $68.31
- MEDP $573.07
- Resistance Level
- DOCU $70.32
- MEDP $609.13
- Average True Range (ATR)
- DOCU 2.10
- MEDP 17.50
- MACD
- DOCU -0.16
- MEDP -2.71
- Stochastic Oscillator
- DOCU 24.02
- MEDP 55.78
About DOCU DocuSign Inc.
Docusign offers Agreement Cloud, a broad cloud-based software suite that enables users to automate the agreement process and provide legally binding e-signatures from nearly any device. The company was founded in 2003 and completed its initial public offering in 2018.
About MEDP Medpace Holdings Inc.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.